Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cush

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Arthritis and Rheumatism|January 13, 2012
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisElizabeth C Hsia, Neil Schluger, John J Cush, et al.
Annals of the Rheumatic Diseases|April 22, 2005
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeksJ C Davis, D M van der Heijde, J Braun, et al.
The Journal of Experimental Medicine|November 27, 2013
RNA recognition by human TLR8 can lead to autoimmune inflammationCristiana Guiducci, Mei Gong, Alma-Martina Cepika, et al.
The Journal of Rheumatology|September 6, 2005
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanerceptJohn C Davis, Désirée M F M Van der Heijde, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateS B Cohen, L W Moreland, J J Cush, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Nature|August 21, 2010
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisMatthew P R Berry, Christine M Graham, Finlay W McNab, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Annals of Internal Medicine|November 6, 2002
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trialJoel M Kremer, Mark C Genovese, Grant W Cannon, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Arthritis and Rheumatism|January 13, 2012
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisElizabeth C Hsia, Neil Schluger, John J Cush, et al.
Annals of the Rheumatic Diseases|April 22, 2005
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeksJ C Davis, D M van der Heijde, J Braun, et al.
The Journal of Experimental Medicine|November 27, 2013
RNA recognition by human TLR8 can lead to autoimmune inflammationCristiana Guiducci, Mei Gong, Alma-Martina Cepika, et al.
The Journal of Rheumatology|September 6, 2005
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanerceptJohn C Davis, Désirée M F M Van der Heijde, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|April 15, 2004
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateS B Cohen, L W Moreland, J J Cush, et al.
Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.
Nature|August 21, 2010
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisMatthew P R Berry, Christine M Graham, Finlay W McNab, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Annals of Internal Medicine|November 6, 2002
Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trialJoel M Kremer, Mark C Genovese, Grant W Cannon, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 7